Abstract 68 Table 3 Variation in median% LDL-C reduction based on Background lipid lowering therapy

Background lipid lowering therapyMedian% LDL-C reduction
3 months 6 months 12 months
Maximum lipid lowering therapy 59.0% 53.0% 68.0%
Statin intolerant 48.0% 51.5% 45.0%
Lipoprotein apheresis 40.0% 41.5% *
  • *To date only two patients on lipoprotein apheresis have completed 12 months of therapy, one patient has achieved an LDL-C reduction of 30%; the other patient has achieved a total cholesterol (TC) reduction of 48% (unable to obtain value for LDL-C due to high triglyceride level).